Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now OTC Markets OTCPK - Delayed Quote • USD Immutep Limited (PRRUF) Follow Compare 0.2000 0.0000 (0.00%) At close: April 2 at 4:00:00 PM EDT Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for PRRUF 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: PRRUF View More All News Press Releases SEC Filings Immutep to Participate in Upcoming Investor Conferences First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025 Immutep Limited (IMMP): Among the Best Australian Stocks to Buy According to Billionaires Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? Immutep Quarterly Activities Report Q2 FY25 Is Immutep Limited (IMMP) One of the Best ASX Stocks to Buy According to Hedge Funds? Why Immutep (IMMP) Is Among the Best Australian Stocks to Buy Now? Patient Enrolment Completed for EFTISARC-NEO Phase II Trial Immutep Limited (ASX:IMM) is largely controlled by institutional shareholders who own 51% of the company Patient Enrolment Completed for INSIGHT-003